期刊论文详细信息
Endocrine Journal
Transcatheter Arterial Embolization for the Treatment of Liver Metastases in a Patient with Malignant Pheochromocytoma
Mika TSUIKI2  Kazue TAKANO2  Nobuyuki TORII1  Daisuke WATANABE2  Akiyo TANABE2  Mitsuhide NARUSE3  Takao NOSHIRO4 
[1] Department of Medicine, Institute of Clinical Gastroenterology, Tokyo Women's Medical University;Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women's Medical University;Division of Endocrinology, Clinical Research Institute of Endocrine and Metabolic Diseases, Kyoto Medical Center;Noshiro Clinic
关键词: Malignant pheochromocytoma;    Multiple hepatic tumors;    Transcatheter arterial embolization (TAE);    Chromogranin A;   
DOI  :  10.1507/endocrj.53.59
学科分类:内分泌与代谢学
来源: Japan Endocrine Society
PDF
【 摘 要 】

References(24)Cited-By(8)A 63-year-old male patient was admitted for the treatment of malignant pheochromocytoma with multiple liver metastases. Plasma and urinary levels of catecholamines were elevated. Transcatheter arterial embolization (TAE) with concomitant administration of mitomycin C and gelatin sponge was performed for the treatment of liver metastases. Dose of alpha-1 blocker before TAE was increased to prevent hypertensive crisis during and after TAE. The hepatic metastatic lesion of CT findings was decreased after TAE. Although blood pressure showed a transient hypertension (180/100 mmHg) after every TAE, it returned rapidly to normal. The patient experienced transient abdominal pain, nausea, and loss of appetite after every TAE; however, those symptoms were readily controlled by conventional medications. Slight elevation of liver transaminases was recognized but returned to normal range within 3 weeks. No other major side effects were seen with TAE. While plasma and urinary level of catecholamines were unchanged, plasma chromogranin A (CgA) level was significantly decreased. These results suggest that TAE is a useful treatment for hepatic metastases. Plasma CgA level is a useful marker in the treatment of malignant pheochromocytoma.

【 授权许可】

Unknown   

【 预 览 】
附件列表
Files Size Format View
RO201911300709070ZK.pdf 1851KB PDF download
  文献评价指标  
  下载次数:4次 浏览次数:1次